Brian Abel, PhD, MBA

Director of Technical Business Development
immunoSCAPE

Disclosure: ImmunoScape (Shareholder)

Presentation(s):

• LB-18 - Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation

  Saturday, October 24, 2020
  2:45pm – 2:55pm EDT